Tyra Biosciences Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 12.20 M | $320.70 M | 0.00% | 20.44% |
| NEXTECH INVEST, LTD. | 02/17/2026 | 4.06 M | $106.63 M | 0.00% | 6.80% |
| ALTA PARTNERS MANAGEMENT COMPANY, L.P. | 01/13/2026 | 3.82 M | $100.52 M | -6.30% | 6.41% |
| COMMODORE CAPITAL LP | 02/17/2026 | 3.38 M | $88.73 M | 0.00% | 5.66% |
| CANAAN PARTNERS XI LLC | 02/13/2026 | 3.37 M | $88.71 M | -6.48% | 5.65% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 2.94 M | $77.08 M | 2.11% | 4.92% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/17/2026 | 2.90 M | $76.19 M | 0.00% | 4.86% |
| VESTAL POINT CAPITAL, LP | 02/17/2026 | 2.43 M | $63.75 M | 0.00% | 4.06% |
| BVF INC/IL | 02/17/2026 | 2.13 M | $55.94 M | -41.70% | 3.57% |
| BLACKROCK, INC. | 02/12/2026 | 2.09 M | $54.85 M | 11.60% | 3.50% |
| FARALLON CAPITAL MANAGEMENT LLC | 02/17/2026 | 2.07 M | $54.34 M | 80.69% | 3.46% |
| VANGUARD GROUP INC | 01/29/2026 | 1.57 M | $41.35 M | 3.46% | 2.64% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/17/2026 | 1.56 M | $41.13 M | -32.85% | 2.62% |
| 5AM VENTURE MANAGEMENT, LLC | 02/17/2026 | 1.03 M | $27.06 M | 9.58% | 1.73% |
| CALIGAN PARTNERS LP | 02/17/2026 | 944.26 K | $24.82 M | 35.51% | 1.58% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 874.19 K | $22.98 M | 209.96% | 1.47% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 818.33 K | $21.51 M | -3.34% | 1.37% |
| STATE STREET CORP | 02/13/2026 | 749.46 K | $19.70 M | 74.92% | 1.26% |
| MARSHALL WACE, LLP | 02/13/2026 | 711.89 K | $18.72 M | 18.25% | 1.19% |
| 02/17/2026 | 700.00 K | $18.40 M | 100.00% | 1.17% | |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 657.76 K | $17.30 M | 10.09% | 1.10% |
| SIO CAPITAL MANAGEMENT, LLC | 02/17/2026 | 526.00 K | $13.83 M | 2.15% | 0.88% |
| BOONE CAPITAL MANAGEMENT LLC | 02/17/2026 | 398.48 K | $10.48 M | 100.00% | 0.67% |
| 02/17/2026 | 350.00 K | $9.20 M | 100.00% | 0.59% | |
| EVERSEPT PARTNERS, LP | 02/17/2026 | 278.56 K | $7.32 M | 2.15% | 0.47% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 221.18 K | $5.81 M | 18.49% | 0.37% |
| LOGOS GLOBAL MANAGEMENT LP | 02/17/2026 | 210.00 K | $5.52 M | 100.00% | 0.35% |
| NORTHERN TRUST CORP | 02/17/2026 | 200.96 K | $5.28 M | -3.61% | 0.34% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 199.43 K | $5.24 M | -1.07% | 0.33% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 182.39 K | $4.79 M | 82.11% | 0.31% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 170.03 K | $4.47 M | 34.55% | 0.29% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/13/2026 | 129.78 K | $3.41 M | 100.00% | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 02/13/2026 | 129.75 K | $3.41 M | -48.42% | 0.22% |
| INVESCO LTD. | 02/19/2026 | 129.44 K | $3.40 M | 734.53% | 0.22% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/12/2026 | 125.00 K | $3.29 M | 100.00% | 0.21% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 120.28 K | $3.16 M | -6.68% | 0.20% |
| MORGAN STANLEY | 02/13/2026 | 118.90 K | $3.13 M | -63.09% | 0.20% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 114.39 K | $3.01 M | -20.57% | 0.19% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 107.02 K | $2.81 M | -46.34% | 0.18% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 104.31 K | $2.74 M | 25.86% | 0.17% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 95.64 K | $2.51 M | 141.03% | 0.16% |
| INVESTMENT COUNSEL CO OF NEVADA | 02/13/2026 | 85.02 K | $2.24 M | 0.00% | 0.14% |
| OPPENHEIMER & CO INC | 02/02/2026 | 84.73 K | $2.23 M | 3.03% | 0.14% |
| 04/02/2026 | 79.56 K | $2.09 M | 100.00% | 0.13% | |
| BARCLAYS PLC | 02/13/2026 | 76.31 K | $2.01 M | 33.58% | 0.13% |
| 02/13/2026 | 74.47 K | $1.96 M | 100.00% | 0.12% | |
| JPMORGAN CHASE & CO | 02/11/2026 | 71.18 K | $1.87 M | -4.11% | 0.12% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 60.90 K | $1.60 M | 6.54% | 0.10% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 58.90 K | $1.55 M | -47.97% | 0.10% |
| UBS GROUP AG | 01/29/2026 | 58.86 K | $1.55 M | -0.49% | 0.10% |
Tyra Biosciences Inc institutional Ownership - FAQ's
During the previous two years, 152 institutional investors and hedge funds held shares of Tyra Biosciences Inc. The most heavily invested institutionals were:
Alta Partners Management Company, L.P.: 3.82 M
Canaan Partners XI LLC: 750,000
OPPENHEIMER & CO INC: 84,192
Bank of New York Mellon Corp: 72,213
UBS Group AG: 61,561
Nuveen, LLC: 50,840
95.24% of Tyra Biosciences Inc stock is owned by institutional investors.
Institutional investors have bought a total of 65.22 M shares in the last 24 months. This purchase volume represents approximately $2.20 B in transactions.